Maha govt to issue circular for rational use of remdesivir
Maharashtra Health Minister Rajesh Tope on Friday said the state government will issue a circular within 24 hours to all doctors and COVID-19 hospitals asking for rational use of remdesivir injections.
- Country:
- India
Maharashtra Health Minister Rajesh Tope on Friday said the state government will issue a circular within 24 hours to all doctors and COVID-19 hospitals asking for rational use of remdesivir injections. FDA minister Dr Rajendra Shingne informed that a special campaign will be launched against black -marketing of the anti-viral injection in the state.
The two ministers were addressing the media after a review meeting on the COVID-19 situation in East Vidarbha. Tope visited government hospitals in Bhandara, Gondia and Nagpur to take stock of the situation and steps taken by the administration.
When asked about excess use and shortage of remdesivir in COVID-19 hospitals, Tope said, "Rational use of the injection is important and it should not be administered as soon as a patient is admitted." Doctors and COVID-19 hospitals will be given directions on how to use remdesivir and a circular will be issued within 24 hours, he said. Speaking about the supply of the drug, Shingne said, "By September 30, around 1.10 lakh remdesivir injections will be available in Maharashtra from five to six pharmaceutical companies that are producing the drug." The FDA along with the home department will launch a special campaign against black marketing of remdesivir across the state and the initiative has already started in Mumbai, the minister said.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Rajesh Tope
- Rajendra Shingne
- COVID
- Maharashtra
- FDA
- East Vidarbha
- Gondia
- Bhandara
- Nagpur
- Mumbai
ALSO READ
Health News Roundup: Some doses of Lilly's Mounjaro in tight supply through April, US FDA says; US takes next step in Medicare drug price negotiations with pharma companies and more
Health News Roundup: US FDA approves Basilea Pharmaceutica's antibiotic; Lack of immunity raises risk of bird flu pandemic, EFSA says and more
Health News Roundup: US FDA approves Basilea Pharmaceutica's antibiotic, Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says and more
Health News Roundup: AstraZeneca's Imfinzi shows promise in treating aggressive lung cancer; US FDA issues warning letters to retailers against underage sale of ZYN nicotine pouches and more
Health News Roundup: Geneos cancer vaccine shrinks liver tumors in small trial; US FDA declines to approve Supernus' Parkinson's combination again and more